{"transactions":[{"id":742904,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-10T19:08:23.000Z","date":"2026-06-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":3964,"price":8,"value":31712.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units."}],"balance_after":374083,"source":{"system":"sec-edgar","filing":"0001196632-26-000017","document":"wk-form4_1781118501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000119663226000017/wk-form4_1781118501.xml","form_type":"4"}},{"id":795389,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-01T20:27:42.000Z","date":"2026-04-29","kind":"grant","planned":false,"acquired":true,"shares":162680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"The restricted stock unit grant was approved by the Compensation Committee of Emergent BioSolutions Inc. (the \"Company\"), on March 2, 2026, subject to stockholder approval of an amendment of the Company's 2006 Stock Incentive Plan (the \"Amended Stock Incentive Plan\"), under which the restricted stock units were granted. The Company's stockholders approved the Amended Stock Incentive Plan on April 29, 2026."},{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of restricted stock units granted under the Company's Amended Stock Incentive Plan. These restricted stock units vest in three annual installments beginning on the anniversary of the date of approval, assuming continued service with the Company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":378047,"source":{"system":"sec-edgar","filing":"0001196632-26-000013","document":"wk-form4_1777667258.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000119663226000013/wk-form4_1777667258.xml","form_type":"4"}},{"id":855632,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2026-03-06T13:50:53.000Z","date":"2026-02-25","kind":"other","planned":false,"acquired":false,"shares":20321,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported stock options expired unexercised pursuant to their terms and no value was received."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vested in three equal installments beginning on the day prior to the first anniversary of the date of grant, subject to continued service with the company."}],"balance_after":0,"derivative":{"exercise_price":61.01,"expiration_date":"2026-02-25","underlying":"Common Stock","underlying_shares":20321},"source":{"system":"sec-edgar","filing":"0001196632-26-000011","document":"wk-form4_1772805051.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000119663226000011/wk-form4_1772805051.xml","form_type":"4"}},{"id":855631,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2026-03-06T13:50:53.000Z","date":"2025-05-07","kind":"other","planned":false,"acquired":false,"shares":19963,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported stock options expired unexercised pursuant to their terms and no value was received."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vested in three equal installments on May 7, 2019, May 7, 2020 and May 7, 2021."}],"balance_after":0,"derivative":{"exercise_price":48.33,"expiration_date":"2025-05-07","underlying":"Common Stock","underlying_shares":19963},"source":{"system":"sec-edgar","filing":"0001196632-26-000011","document":"wk-form4_1772805051.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000119663226000011/wk-form4_1772805051.xml","form_type":"4"}},{"id":858068,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2026-03-06T02:07:03.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":72856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":557346,"derivative":{"exercise_price":8.99,"expiration_date":"2033-03-02","underlying":"Common Stock","underlying_shares":72856},"source":{"system":"sec-edgar","filing":"0001196632-26-000009","document":"wk-form4_1772762821.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000119663226000009/wk-form4_1772762821.xml","form_type":"4"}},{"id":858067,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-06T02:07:03.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":23650,"price":8.44,"value":199606.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units"}],"balance_after":215367,"source":{"system":"sec-edgar","filing":"0001196632-26-000009","document":"wk-form4_1772762821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000119663226000009/wk-form4_1772762821.xml","form_type":"4"}},{"id":865937,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-03T21:32:31.000Z","date":"2026-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":683,"price":8.15,"value":5566.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units."}],"balance_after":239017,"source":{"system":"sec-edgar","filing":"0001196632-26-000006","document":"wk-form4_1772573548.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000119663226000006/wk-form4_1772573548.xml","form_type":"4"}},{"id":911580,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-11T00:06:19.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":5642,"price":10.92,"value":61610.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units"}],"balance_after":239700,"source":{"system":"sec-edgar","filing":"0001196632-26-000003","document":"wk-form4_1770768376.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000119663226000003/wk-form4_1770768376.xml","form_type":"4"}},{"id":911579,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-11T00:06:19.000Z","date":"2026-02-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":46155,"price":10.92,"value":504012.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to both cumulative revenues and adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025. On February 06, 2026, the final certification date, the Compensation Committee certified the achievement of the 2023-2025 PSUs at a payout factor of 25% of target resulting in the actual award of 15,384 shares of common stock, which is less than the 61,539 shares previously reported on March 02, 2023 and June 09, 2023."}],"balance_after":245342,"source":{"system":"sec-edgar","filing":"0001196632-26-000003","document":"wk-form4_1770768376.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000119663226000003/wk-form4_1770768376.xml","form_type":"4"}},{"id":951651,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-05T21:33:21.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This grant vests in full upon the earlier of (i) June 10, 2026 or (ii) the date of the next annual meeting of the Company's stockholders."}],"balance_after":90000,"derivative":{"exercise_price":5.17,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001171843-26-000058","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738021/000117184326000058/ownership.xml","form_type":"4"}},{"id":1016439,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-17T20:02:38.000Z","date":"2025-10-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":4995,"price":9.6,"value":47952.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units."}],"balance_after":291497,"source":{"system":"sec-edgar","filing":"0001196632-25-000004","document":"wk-form4_1760731355.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000119663225000004/wk-form4_1760731355.xml","form_type":"4"}},{"id":1116138,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-10T20:07:00.000Z","date":"2025-06-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":2733,"price":6.63,"value":18119.79,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units."}],"balance_after":296492,"source":{"system":"sec-edgar","filing":"0001367644-25-000138","document":"wk-form4_1749586014.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764425000138/wk-form4_1749586014.xml","form_type":"4"}},{"id":1214791,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2025-03-10T20:18:03.000Z","date":"2025-03-06","kind":"grant","planned":false,"acquired":true,"shares":178546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":484490,"derivative":{"exercise_price":5.8,"expiration_date":"2032-03-05","underlying":"Common Stock","underlying_shares":178546},"source":{"system":"sec-edgar","filing":"0001367644-25-000051","document":"wk-form4_1741637877.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764425000051/wk-form4_1741637877.xml","form_type":"4"}},{"id":1214790,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-10T20:18:03.000Z","date":"2025-03-06","kind":"grant","planned":false,"acquired":true,"shares":146888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three annual installments beginning on the day prior to the  anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":299225,"source":{"system":"sec-edgar","filing":"0001367644-25-000051","document":"wk-form4_1741637877.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764425000051/wk-form4_1741637877.xml","form_type":"4"}},{"id":1227302,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-04T21:05:01.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":683,"price":7.48,"value":5108.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units"}],"balance_after":152337,"source":{"system":"sec-edgar","filing":"0001367644-25-000030","document":"wk-form4_1741122292.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764425000030/wk-form4_1741122292.xml","form_type":"4"}},{"id":1227301,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-04T21:05:01.000Z","date":"2025-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":1073,"price":7.48,"value":8026.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units"}],"balance_after":153020,"source":{"system":"sec-edgar","filing":"0001367644-25-000030","document":"wk-form4_1741122292.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764425000030/wk-form4_1741122292.xml","form_type":"4"}},{"id":1227300,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-04T21:05:01.000Z","date":"2025-02-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA margin calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period. On February 12, 2025, the final certification date, the Compensation Committee certified the achievement of the 2022-2024 PSUs at a payout factor of 0.00% of target resulting in the actual award of 0 shares of common stock, which is below the 16,916 shares previously reported on March 1, 2022."}],"balance_after":154093,"source":{"system":"sec-edgar","filing":"0001367644-25-000030","document":"wk-form4_1741122292.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764425000030/wk-form4_1741122292.xml","form_type":"4"}},{"id":1269705,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-13T22:11:36.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over 48 substantially equal monthly installments starting March 11, 2025."}],"balance_after":40000,"derivative":{"exercise_price":3.65,"expiration_date":"2035-02-11","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001171843-25-000830","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738021/000117184325000830/ownership.xml","form_type":"4"}},{"id":1384629,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-10-17T21:04:36.000Z","date":"2024-10-15","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in one annual installment beginning on the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":171009,"source":{"system":"sec-edgar","filing":"0001367644-24-000164","document":"wk-form4_1729199070.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764424000164/wk-form4_1729199070.xml","form_type":"4"}},{"id":1483186,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-11T20:10:21.000Z","date":"2024-06-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":2733,"price":6.19,"value":16917.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":156009,"source":{"system":"sec-edgar","filing":"0001367644-24-000105","document":"wk-form4_1718136614.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764424000105/wk-form4_1718136614.xml","form_type":"4"}},{"id":1574456,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2024-03-15T21:15:48.000Z","date":"2024-03-13","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":305944,"derivative":{"exercise_price":2.33,"expiration_date":"2031-03-12","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001367644-24-000041","document":"wk-form4_1710537332.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764424000041/wk-form4_1710537332.xml","form_type":"4"}},{"id":1602631,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-04T23:42:50.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":684,"price":3.39,"value":2318.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":158742,"source":{"system":"sec-edgar","filing":"0001367644-24-000021","document":"wk-form4_1709595761.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764424000021/wk-form4_1709595761.xml","form_type":"4"}},{"id":1602630,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-04T23:42:50.000Z","date":"2024-02-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":9037,"price":3.23,"value":29189.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":159426,"source":{"system":"sec-edgar","filing":"0001367644-24-000021","document":"wk-form4_1709595761.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764424000021/wk-form4_1709595761.xml","form_type":"4"}},{"id":1615171,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-28T01:26:40.000Z","date":"2024-02-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":517,"price":2.74,"value":1416.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":168463,"source":{"system":"sec-edgar","filing":"0001367644-24-000008","document":"wk-form4_1709083590.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764424000008/wk-form4_1709083590.xml","form_type":"4"}},{"id":1615170,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-28T01:26:40.000Z","date":"2024-02-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4012,"price":2.71,"value":10872.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA margin calculated on a cumulative basis over the three-year period beginning January 1, 2021 and ending December 31, 2023, as certified by the Compensation Committee following the performance period.  On February 21, 2024, the final certification date, the Compensation Committee certified the achievement of the 2021-2023 PSUs at a payout factor of 0.00% of target resulting in the actual award of 0 shares of common stock, which is below the 4,012 shares previously reported on February 24, 2021."}],"balance_after":168980,"source":{"system":"sec-edgar","filing":"0001367644-24-000008","document":"wk-form4_1709083590.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764424000008/wk-form4_1709083590.xml","form_type":"4"}},{"id":1643244,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-14T17:03:16.000Z","date":"2024-02-09","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over 48 substantially equal monthly installments starting March 9, 2024."}],"balance_after":40000,"derivative":{"exercise_price":1.57,"expiration_date":"2034-02-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001171843-24-000795","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738021/000117184324000795/ownership.xml","form_type":"4"}},{"id":1857028,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2023-06-14T01:21:54.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":49231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Represents the corrected number of securities owned due to a computational error in prior Form-4s"}],"balance_after":180944,"derivative":{"exercise_price":8.39,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":49231},"source":{"system":"sec-edgar","filing":"0001367644-23-000122","document":"wk-form4_1686705705.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764423000122/wk-form4_1686705705.xml","form_type":"4"}},{"id":1857027,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-14T01:21:54.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":49231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to both cumulative revenues and adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025, as certified by the Compensation Committee following the performance period.  The amount reported is based on the target performance payout factor, or 100%."}],"balance_after":172992,"source":{"system":"sec-edgar","filing":"0001367644-23-000122","document":"wk-form4_1686705705.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764423000122/wk-form4_1686705705.xml","form_type":"4"}},{"id":1857026,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-14T01:21:54.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":24616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the company's Stock Incentive Plan.  These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company or the day prior to the annual shareholder meeting; whichever is earlier. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":123761,"source":{"system":"sec-edgar","filing":"0001367644-23-000122","document":"wk-form4_1686705705.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764423000122/wk-form4_1686705705.xml","form_type":"4"}},{"id":1914933,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-24T20:32:59.000Z","date":"2023-04-21","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over 48 substantially equal monthly installments starting May 21, 2023."}],"balance_after":50000,"derivative":{"exercise_price":2.91,"expiration_date":"2033-04-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001171843-23-002483","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738021/000117184323002483/ownership.xml","form_type":"4"}},{"id":1968656,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2023-03-07T00:36:21.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":12308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents the corrected number of securities owned due to a computational error on prior Form-4."}],"balance_after":93049,"derivative":{"exercise_price":12.06,"expiration_date":"2030-03-01","underlying":"Common Stock","underlying_shares":12308},"source":{"system":"sec-edgar","filing":"0001367644-23-000068","document":"wf-form4_167814936251398.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764423000068/wf-form4_167814936251398.xml","form_type":"4"}},{"id":1968655,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-07T00:36:21.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":12308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025, as certified by the Compensation Committee following the performance period.  The amount reported is based on the target performance payout factor, or 100%."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents the corrected number of securities owned due to a computational error on prior Form-4."}],"balance_after":99145,"source":{"system":"sec-edgar","filing":"0001367644-23-000068","document":"wf-form4_167814936251398.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764423000068/wf-form4_167814936251398.xml","form_type":"4"}},{"id":1968654,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-07T00:36:21.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":6154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the company's Stock Incentive Plan.  These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company or the day prior to the annual shareholder meeting; whichever is earlier. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents the corrected number of securities owned due to a computational error on prior Form-4."}],"balance_after":86837,"source":{"system":"sec-edgar","filing":"0001367644-23-000068","document":"wf-form4_167814936251398.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764423000068/wf-form4_167814936251398.xml","form_type":"4"}},{"id":1979017,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-02T19:42:49.000Z","date":"2023-02-28","kind":"tax_withholding","acquired":false,"shares":1074,"price":12.38,"value":13296.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":16906,"source":{"system":"sec-edgar","filing":"0001367644-23-000057","document":"wf-form4_167778614592939.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764423000057/wf-form4_167778614592939.xml","form_type":"4"}},{"id":1989924,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-28T01:22:59.000Z","date":"2023-02-24","kind":"tax_withholding","acquired":false,"shares":977,"price":13.71,"value":13394.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":17980,"source":{"system":"sec-edgar","filing":"0001367644-23-000035","document":"wf-form4_167754736499121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764423000035/wf-form4_167754736499121.xml","form_type":"4"}},{"id":1989923,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-28T01:22:59.000Z","date":"2023-02-23","kind":"tax_withholding","acquired":false,"shares":444,"price":14.3,"value":6349.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":18957,"source":{"system":"sec-edgar","filing":"0001367644-23-000035","document":"wf-form4_167754736499121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764423000035/wf-form4_167754736499121.xml","form_type":"4"}},{"id":2022423,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-11T01:35:01.000Z","date":"2023-02-08","kind":"tax_withholding","acquired":false,"shares":2396,"price":13.25,"value":31747.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":19401,"source":{"system":"sec-edgar","filing":"0001367644-23-000014","document":"wf-form4_167607927638617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764423000014/wf-form4_167607927638617.xml","form_type":"4"}},{"id":2022422,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-11T01:35:01.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2022 fiscal year, as certified by the Compensation Committee following the performance period. On February 08, 2023, the final certification date, the Compensation Committee certified the achievement of the 2020-2022 PSUs at a payout factor of 101.67% of target resulting in the actual award of 6,205 shares of common stock, which is in excess of the 6,104 shares previously reported on February 25, 2020."}],"balance_after":21797,"source":{"system":"sec-edgar","filing":"0001367644-23-000014","document":"wf-form4_167607927638617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764423000014/wf-form4_167607927638617.xml","form_type":"4"}},{"id":2359962,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2022-03-02T23:46:20.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":38664,"price":41.38,"value":1599916.32,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":38664,"derivative":{"exercise_price":41.38,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":38664},"source":{"system":"sec-edgar","filing":"0001367644-22-000042","document":"wf-form4_164626472010733.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764422000042/wf-form4_164626472010733.xml","form_type":"4"}},{"id":2359961,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-02T23:46:20.000Z","date":"2022-02-28","kind":"tax_withholding","acquired":false,"shares":818,"price":39.64,"value":32425.52,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes."}],"balance_after":85473,"source":{"system":"sec-edgar","filing":"0001367644-22-000042","document":"wf-form4_164626472010733.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764422000042/wf-form4_164626472010733.xml","form_type":"4"}},{"id":2359960,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-02T23:46:20.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":16916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period.  The amount reported is based on the target performance payout factor, or 100%."}],"balance_after":86291,"source":{"system":"sec-edgar","filing":"0001367644-22-000042","document":"wf-form4_164626472010733.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764422000042/wf-form4_164626472010733.xml","form_type":"4"}},{"id":2359959,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-02T23:46:20.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":31417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest either in three equal annual installments beginning on the day prior to the first anniversary of the date of grant (9,667 shares) or on the day prior to the second anniversary date of the grant (21,750 shares), assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":69375,"source":{"system":"sec-edgar","filing":"0001367644-22-000042","document":"wf-form4_164626472010733.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764422000042/wf-form4_164626472010733.xml","form_type":"4"}},{"id":2371658,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-25T22:18:22.000Z","date":"2022-02-24","kind":"tax_withholding","acquired":false,"shares":983,"price":42.47,"value":41748.01,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes."}],"balance_after":37958,"source":{"system":"sec-edgar","filing":"0001367644-22-000032","document":"wf-form4_164582747302451.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764422000032/wf-form4_164582747302451.xml","form_type":"4"}},{"id":2371657,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-25T22:18:22.000Z","date":"2022-02-23","kind":"tax_withholding","acquired":false,"shares":516,"price":42.23,"value":21790.68,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes."}],"balance_after":38941,"source":{"system":"sec-edgar","filing":"0001367644-22-000032","document":"wf-form4_164582747302451.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764422000032/wf-form4_164582747302451.xml","form_type":"4"}},{"id":2374350,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-24T23:53:56.000Z","date":"2022-02-22","kind":"tax_withholding","acquired":false,"shares":2298,"price":42.23,"value":97044.54,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":39457,"source":{"system":"sec-edgar","filing":"0001367644-22-000020","document":"wf-form4_164574681773856.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764422000020/wf-form4_164574681773856.xml","form_type":"4"}},{"id":2374349,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-24T23:53:56.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":1836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2021 fiscal year, as certified by the Compensation Committee following the performance period. On February 22, 2022, the final certification date, the Compensation Committee certified the achievement of the 2019-2021 PSUs at a payout factor of 136.14% of target resulting in the actual award of 6,917 shares of common stock, which is in excess of the 5,081 shares previously reported on February 28, 2019."}],"balance_after":41755,"source":{"system":"sec-edgar","filing":"0001367644-22-000020","document":"wf-form4_164574681773856.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764422000020/wf-form4_164574681773856.xml","form_type":"4"}},{"id":2512511,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-11-15T22:53:15.000Z","date":"2021-11-15","kind":"purchase","acquired":true,"shares":3000,"price":37.46,"value":112380.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $37.32 to $37.63."}],"balance_after":39919,"source":{"system":"sec-edgar","filing":"0001367644-21-000144","document":"wf-form4_163701676472498.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764421000144/wf-form4_163701676472498.xml","form_type":"4"}},{"id":2718288,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-11T20:27:47.000Z","date":"2021-05-08","kind":"tax_withholding","acquired":false,"shares":1054,"price":61.62,"value":64947.48,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon vest of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":36919,"source":{"system":"sec-edgar","filing":"0001367644-21-000079","document":"wf-form4_162076485462525.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764421000079/wf-form4_162076485462525.xml","form_type":"4"}},{"id":2829291,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2021-02-26T22:12:59.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":16043,"price":93.49,"value":1499860.07,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":16043,"derivative":{"exercise_price":93.49,"expiration_date":"2028-02-23","underlying":"Common Stock","underlying_shares":16043},"source":{"system":"sec-edgar","filing":"0001367644-21-000041","document":"wf-form4_161437750812785.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764421000041/wf-form4_161437750812785.xml","form_type":"4"}},{"id":2829290,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-26T22:12:59.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":819,"price":97.15,"value":79565.85,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":37973,"source":{"system":"sec-edgar","filing":"0001367644-21-000041","document":"wf-form4_161437750812785.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764421000041/wf-form4_161437750812785.xml","form_type":"4"}},{"id":2829289,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-26T22:12:59.000Z","date":"2021-02-24","kind":"tax_withholding","acquired":false,"shares":1010,"price":93.49,"value":94424.9,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":38792,"source":{"system":"sec-edgar","filing":"0001367644-21-000041","document":"wf-form4_161437750812785.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764421000041/wf-form4_161437750812785.xml","form_type":"4"}},{"id":2829288,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-26T22:12:59.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":4012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA margin calculated on a cumulative basis over the three-year period beginning January 1, 2021 and ending December 31, 2023, as certified by the Compensation Committee following the performance period.  The amount reported is based on the target performance payout factor, or 100%."}],"balance_after":39802,"source":{"system":"sec-edgar","filing":"0001367644-21-000041","document":"wf-form4_161437750812785.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764421000041/wf-form4_161437750812785.xml","form_type":"4"}},{"id":2829287,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-26T22:12:59.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":4011,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":35790,"source":{"system":"sec-edgar","filing":"0001367644-21-000041","document":"wf-form4_161437750812785.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764421000041/wf-form4_161437750812785.xml","form_type":"4"}},{"id":2866228,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-12T02:20:14.000Z","date":"2021-02-09","kind":"tax_withholding","acquired":false,"shares":2522,"price":123.45,"value":311340.9,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares of common stock withheld to pay taxes due upon vesting of the PSUs."}],"balance_after":31779,"source":{"system":"sec-edgar","filing":"0001367644-21-000010","document":"wf-form4_161309639586111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764421000010/wf-form4_161309639586111.xml","form_type":"4"}},{"id":2866227,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-12T02:20:14.000Z","date":"2021-02-09","kind":"grant","acquired":true,"shares":2495,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of Performance Stock Units (\"PSUs\") previously granted on May 8, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year, as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 7,486 shares of common stock, which is in excess of the 4,991 shares previously reported on May 10, 2018."},{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of Performance Stock Units (\"PSUs\") previously granted on May 8, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year, as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 7,486 shares of common stock, which is in excess of the 4,991 shares previously reported on May 10, 2018."}],"balance_after":34301,"source":{"system":"sec-edgar","filing":"0001367644-21-000010","document":"wf-form4_161309639586111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764421000010/wf-form4_161309639586111.xml","form_type":"4"}},{"id":3152361,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-05-12T20:21:22.000Z","date":"2020-05-08","kind":"tax_withholding","acquired":false,"shares":728,"price":79.25,"value":57694.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":31806,"source":{"system":"sec-edgar","filing":"0001367644-20-000055","document":"wf-form4_158931486324853.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764420000055/wf-form4_158931486324853.xml","form_type":"4"}},{"id":3243536,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2020-02-28T02:20:13.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":24414,"price":61.44,"value":1499996.16,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":44735,"derivative":{"exercise_price":61.44,"expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":24414},"source":{"system":"sec-edgar","filing":"0001367644-20-000017","document":"wf-form4_158285639623403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764420000017/wf-form4_158285639623403.xml","form_type":"4"}},{"id":3243535,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-02-28T02:20:13.000Z","date":"2020-02-26","kind":"tax_withholding","acquired":false,"shares":610,"price":59.91,"value":36545.1,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":32534,"source":{"system":"sec-edgar","filing":"0001367644-20-000017","document":"wf-form4_158285639623403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764420000017/wf-form4_158285639623403.xml","form_type":"4"}},{"id":3243534,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-02-28T02:20:13.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":6104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue for the three year period 2020 - 2022 fiscal years, as certified by the Compensation Committee following the performance period."}],"balance_after":33144,"source":{"system":"sec-edgar","filing":"0001367644-20-000017","document":"wf-form4_158285639623403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764420000017/wf-form4_158285639623403.xml","form_type":"4"}},{"id":3243533,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-02-28T02:20:13.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":6103,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":27040,"source":{"system":"sec-edgar","filing":"0001367644-20-000017","document":"wf-form4_158285639623403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000136764420000017/wf-form4_158285639623403.xml","form_type":"4"}},{"id":3531247,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-05-10T22:14:22.000Z","date":"2019-05-08","kind":"tax_withholding","acquired":false,"shares":759,"price":47.49,"value":36044.91,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":20937,"source":{"system":"sec-edgar","filing":"0001567619-19-010458","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000156761919010458/doc1.xml","form_type":"4"}},{"id":3625873,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-03-01T00:06:29.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":20321,"price":61.01,"value":1239784.21,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company."}],"balance_after":20321,"derivative":{"exercise_price":61.01,"expiration_date":"2026-02-25","underlying":"Common Stock","underlying_shares":20321},"source":{"system":"sec-edgar","filing":"0001567619-19-005674","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000156761919005674/doc1.xml","form_type":"4"}},{"id":3625872,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-03-01T00:06:29.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":5081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan.  Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2021 fiscal year, as certified by the Compensation Committee following the performance period."}],"balance_after":21696,"source":{"system":"sec-edgar","filing":"0001567619-19-005674","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000156761919005674/doc1.xml","form_type":"4"}},{"id":3625871,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-03-01T00:06:29.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":5081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":16615,"source":{"system":"sec-edgar","filing":"0001567619-19-005674","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000156761919005674/doc1.xml","form_type":"4"}},{"id":3938591,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-05-10T21:56:56.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":19963,"price":48.33,"value":964811.79,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments on May 7, 2019, May 7, 2020 and May 7, 2021."}],"balance_after":19963,"derivative":{"exercise_price":48.33,"expiration_date":"2025-05-07","underlying":"Common Stock","underlying_shares":19963},"source":{"system":"sec-edgar","filing":"0001140361-18-022841","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000114036118022841/doc1.xml","form_type":"4"}},{"id":3938590,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-05-10T21:56:56.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":4991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of performance stock units granted under the Amended and Restated 2006 Emergent BioSolutions Inc. Stock Incentive Plan, as amended. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to net income as a percentage of total revenue for the 2020 fiscal year, each as determined in accordance with GAAP, as certified by the Compensation Committee following the performance period."}],"balance_after":11534,"source":{"system":"sec-edgar","filing":"0001140361-18-022841","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000114036118022841/doc1.xml","form_type":"4"}},{"id":3938589,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-05-10T21:56:56.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":1551,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":6543,"source":{"system":"sec-edgar","filing":"0001140361-18-022841","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000114036118022841/doc1.xml","form_type":"4"}},{"id":3938588,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-05-10T21:56:56.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":4992,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":4992,"source":{"system":"sec-edgar","filing":"0001140361-18-022841","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196632/000114036118022841/doc1.xml","form_type":"4"}},{"id":4357032,"issuer":{"id":177136,"kind":"organization","name":"CEB Inc.","symbol":"CEB"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Performance Stock Units","published_at":"2017-04-06T20:52:51.000Z","date":"2017-04-05","kind":"exercise","acquired":false,"shares":7686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represented a right upon vesting (based on the achievement of performance goals at target performance) to receive one share of CEB's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Pursuant to the Merger Agreement, immediately prior to the consummation of the Merger, since certain performance goals were achieved at target performance, each outstanding PSU vested."}],"balance_after":0,"derivative":{"exercise_date":"2017-04-05","expiration_date":"2017-04-05","underlying":"Common Stock","underlying_shares":7686},"source":{"system":"sec-edgar","filing":"0001209191-17-026161","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1066104/000120919117026161/doc4.xml","form_type":"4"}},{"id":4357031,"issuer":{"id":177136,"kind":"organization","name":"CEB Inc.","symbol":"CEB"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2017-04-06T20:52:51.000Z","date":"2017-04-05","kind":"exercise","acquired":false,"shares":23435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each restricted stock unit of CEB (\"RSU\") that did not vest at or before the effectiveness of the Merger was assumed by Gartner and converted into a restricted share unit payable in a number of shares of Gartner common stock, rounded up to the nearest whole share, equal to the product of (i) the applicable number of shares of CEB common stock subject to such award multiplied by (ii) the sum of (x) 0.2284 plus (y) a fraction resulting from dividing $54.00 by the closing price per share of Gartner common stock on the NYSE on the last trading day immediately preceding the closing date of the Merger ($108.70)."},{"field":"shares","element":"transactionShares","label":"F9","text":"RSUs that were awarded on March 26, 2014, March 25, 2015, March 30, 2016 and March 15, 2017 and did not vest at or before the effectiveness of the Merger that rolled over into restricted share units of Gartner."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Pursuant to the Merger Agreement, on the effective date of the Merger, each outstanding RSU that did not vest before or in connection with the Merger rolled over into a restricted share unit of Gartner."}],"balance_after":0,"derivative":{"exercise_date":"2017-04-05","expiration_date":"2017-04-05","underlying":"Common Stock","underlying_shares":23435},"source":{"system":"sec-edgar","filing":"0001209191-17-026161","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1066104/000120919117026161/doc4.xml","form_type":"4"}},{"id":4357030,"issuer":{"id":177136,"kind":"organization","name":"CEB Inc.","symbol":"CEB"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-04-06T20:52:51.000Z","date":"2017-04-05","kind":"disposition_to_issuer","acquired":false,"shares":37852,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Represents the number of shares of common stock of CEB beneficially owned by the reporting person immediately prior to the effectiveness of the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Disposed of pursuant to the Merger Agreement in exchange for per share consideration of (a) $54.00 in cash and (b) 0.2284 of a share of common stock of Gartner. Gartner common stock had a market value of $108.70 per share based on the closing price on the NYSE on the last trading day immediately preceding the Merger (April 4, 2017)."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-17-026161","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1066104/000120919117026161/doc4.xml","form_type":"4"}},{"id":4357029,"issuer":{"id":177136,"kind":"organization","name":"CEB Inc.","symbol":"CEB"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-04-06T20:52:51.000Z","date":"2017-04-05","kind":"disposition_to_issuer","acquired":false,"shares":6433,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the disposition pursuant to the Merger Agreement of the shares underlying the Vested PSUs, net of tax withholding."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Disposed of pursuant to the Merger Agreement in exchange for per share consideration of (a) $54.00 in cash and (b) 0.2284 of a share of common stock of Gartner. Gartner common stock had a market value of $108.70 per share based on the closing price on the NYSE on the last trading day immediately preceding the Merger (April 4, 2017)."}],"balance_after":37852,"source":{"system":"sec-edgar","filing":"0001209191-17-026161","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1066104/000120919117026161/doc4.xml","form_type":"4"}},{"id":4357028,"issuer":{"id":177136,"kind":"organization","name":"CEB Inc.","symbol":"CEB"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-04-06T20:52:51.000Z","date":"2017-04-05","kind":"tax_withholding","acquired":false,"shares":1253,"price":78.85,"value":98799.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares of CEB common stock underlying the Vested PSUs withheld to satisfy tax withholding obligations related to the Vested PSUs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The closing price on the New York Stock Exchange (\"NYSE\") of CEB common stock on April 3, 2017."}],"balance_after":44285,"source":{"system":"sec-edgar","filing":"0001209191-17-026161","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1066104/000120919117026161/doc4.xml","form_type":"4"}},{"id":4357027,"issuer":{"id":177136,"kind":"organization","name":"CEB Inc.","symbol":"CEB"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-04-06T20:52:51.000Z","date":"2017-04-05","kind":"exercise","acquired":true,"shares":7686,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the shares of common stock of CEB Inc. (\"CEB\") acquired upon vesting of the restricted stock units of CEB beneficially owned by the reporting person on the effective date of the merger (\"Merger\") described in the Agreement and Plan of Merger (\"Merger Agreement\") dated as of January 5, 2017, among Gartner, Inc. (\"Gartner\"), Cobra Acquisition Corp. and CEB (\"Vested RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each PSU represented a right upon vesting (based on the achievement of performance goals at target performance) to receive one share of CEB's common stock."}],"balance_after":45538,"source":{"system":"sec-edgar","filing":"0001209191-17-026161","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066104/000120919117026161/doc4.xml","form_type":"4"}},{"id":4369498,"issuer":{"id":177136,"kind":"organization","name":"CEB Inc.","symbol":"CEB"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2017-03-29T16:32:46.000Z","date":"2017-03-27","kind":"exercise","acquired":true,"shares":2208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"N/A"}],"balance_after":0,"derivative":{"exercise_date":"2017-03-27","underlying":"Common Stock","underlying_shares":2208},"source":{"system":"sec-edgar","filing":"0001209191-17-023507","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1066104/000120919117023507/doc4.xml","form_type":"4"}},{"id":4369497,"issuer":{"id":177136,"kind":"organization","name":"CEB Inc.","symbol":"CEB"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2017-03-29T16:32:46.000Z","date":"2017-03-27","kind":"exercise","acquired":true,"shares":1749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"N/A"}],"balance_after":1749,"derivative":{"exercise_date":"2017-03-26","underlying":"Common Stock","underlying_shares":1749},"source":{"system":"sec-edgar","filing":"0001209191-17-023507","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1066104/000120919117023507/doc4.xml","form_type":"4"}},{"id":4369496,"issuer":{"id":177136,"kind":"organization","name":"CEB Inc.","symbol":"CEB"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2017-03-29T16:32:46.000Z","date":"2017-03-27","kind":"exercise","acquired":true,"shares":2051,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"N/A"}],"balance_after":4102,"derivative":{"exercise_date":"2017-03-25","underlying":"Common Stock","underlying_shares":2051},"source":{"system":"sec-edgar","filing":"0001209191-17-023507","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1066104/000120919117023507/doc4.xml","form_type":"4"}},{"id":4369495,"issuer":{"id":177136,"kind":"organization","name":"CEB Inc.","symbol":"CEB"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-03-29T16:32:46.000Z","date":"2017-03-27","kind":"tax_withholding","acquired":false,"shares":744,"price":78.9,"value":58701.6,"ownership":{"direct":true},"balance_after":37852,"source":{"system":"sec-edgar","filing":"0001209191-17-023507","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1066104/000120919117023507/doc4.xml","form_type":"4"}},{"id":4369494,"issuer":{"id":177136,"kind":"organization","name":"CEB Inc.","symbol":"CEB"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-03-29T16:32:46.000Z","date":"2017-03-27","kind":"exercise","acquired":true,"shares":6008,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":38596,"source":{"system":"sec-edgar","filing":"0001209191-17-023507","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066104/000120919117023507/doc4.xml","form_type":"4"}},{"id":4380585,"issuer":{"id":177136,"kind":"organization","name":"CEB Inc.","symbol":"CEB"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2017-03-17T16:17:24.000Z","date":"2017-03-15","kind":"grant","acquired":true,"shares":7561,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units vest equally in four increments in the following months: April 2018, March 2019, March 2020 and March 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"N/A"}],"balance_after":7561,"derivative":{"underlying":"Common Stock","underlying_shares":7561},"source":{"system":"sec-edgar","filing":"0001209191-17-021359","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066104/000120919117021359/doc4.xml","form_type":"4"}},{"id":4436860,"issuer":{"id":177136,"kind":"organization","name":"CEB Inc.","symbol":"CEB"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2017-02-21T16:33:54.000Z","date":"2017-02-17","kind":"exercise","acquired":true,"shares":2255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Performance-Based Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of these Performance-Based Restricted Stock Units was adjusted from the target amount of 2,819 to reflect the actual performance in the three-year period beginning January 1, 2014 and ending December 31, 2016."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"N/A"},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The number of these Performance-Based Restricted Stock Units was adjusted from the target amount of 2,819 to reflect the actual performance in the three-year period beginning January 1, 2014 and ending December 31, 2016."}],"balance_after":0,"derivative":{"exercise_date":"2017-02-17","underlying":"Common Stock","underlying_shares":2255},"source":{"system":"sec-edgar","filing":"0001209191-17-012721","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1066104/000120919117012721/doc4.xml","form_type":"4"}},{"id":4436859,"issuer":{"id":177136,"kind":"organization","name":"CEB Inc.","symbol":"CEB"},"owners":[{"id":39613,"kind":"person","name":"LINDAHL RICHARD S","position":1,"cik":"0001196632","reported_name":"LINDAHL RICHARD S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-02-21T16:33:54.000Z","date":"2017-02-17","kind":"exercise","acquired":true,"shares":2255,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":32588,"source":{"system":"sec-edgar","filing":"0001209191-17-012721","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066104/000120919117012721/doc4.xml","form_type":"4"}}]}